Number of the records: 1
nosiče liekové
SYS d004337 LBL 00000cy--a2200000n--4500 005 20250606214214.6 008 920504|-|anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 $d BA006 $d BA006 $d BA006 $d BA006 065 $a D26.255.260 065 $a E02.319.300.380 066 $a 01 $c 03 150 $a nosiče liekové $x AD $x AE $x AN $x CH $x CL $x CS $x EC $x HI $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $2 slo 450 $w v $a nosiče pre targeting liečiva $2 slo 450 $w v $a nosiče pre cielenú dodávku liečiva $2 slo 550 $7 sllk_us_auth*d000082662 $Y Magnetic Iron Oxide Nanoparticles $w p $a nanočastice oxidov železa, magnetické 550 $7 sllk_us_auth*d016503 $Y Drug Delivery Systems $w b $a systémy pre cielený transport liečiva 550 $7 sllk_us_auth*d000082662 $Y Magnetic Iron Oxide Nanoparticles $w b $a nanočastice oxidov železa, magnetické 665 $a 88 $2 eng 665 $a Delayed-Action Preparations (1966-1987) $2 eng 665 $a Drugs (1966-1987) $2 eng 680 9-
$i Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. $2 eng 680 $a coord with specific drug $2 eng 750 $a Drug Carriers $2 eng 980 $x M
Number of the records: 1